Novo Nordisk Logo

Novo Nordisk

Develops treatments for serious chronic diseases like diabetes, obesity, and hemophilia.

NOVO | CO

Overview

Corporate Details

ISIN(s):
DK0062498333 (+1 more)
LEI:
549300DAQ1CVT6CXN342
Country:
Denmark
Address:
Novo Alle 1, 2880 Bagsværd

Description

Novo Nordisk is a global healthcare company dedicated to developing treatments for serious chronic diseases. With over a century of innovation, it is a world leader in diabetes care, providing a comprehensive portfolio of insulin products and GLP-1 receptor agonists. Leveraging its expertise in metabolic conditions, the company has also become a prominent force in obesity management. Novo Nordisk's therapeutic focus extends to other serious chronic conditions, including rare bleeding disorders like hemophilia and growth hormone-related disorders.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-25 14:19
FORM 6-K
English 215.1 KB
2025-11-25 12:24 English 9.7 KB
2025-11-25 12:24 English 123.1 KB
2025-11-24 13:23
FORM 6-K
English 214.6 KB
2025-11-24 12:20 English 108.1 KB
2025-11-24 12:20 English 9.1 KB
2025-11-17 21:35
FORM 6-K
English 212.4 KB
2025-11-17 14:58 English 16.2 KB
2025-11-17 14:58 English 123.6 KB
2025-11-14 16:12
FORM 6-K
English 211.9 KB
2025-11-14 12:00
FORM 6-K
English 211.4 KB
2025-11-12 12:10
FORM 6-K
English 213.2 KB
2025-11-11 14:39 English 26.7 KB
2025-11-11 14:39 English 155.6 KB
2025-11-07 12:00
FORM 6-K
English 211.6 KB

Automate Your Workflow. Get a real-time feed of all Novo Nordisk filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Novo Nordisk

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Novo Nordisk via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.